Innogenetics(比利時(shí))

Innogenetics

比利時(shí)Innogeneticswww.innogenetics.com www.solvay.comInnogenetics為比利時(shí)分子診斷公司INNOGENETICS專心致力于研究InfectiousDiseases,GeneticTesting,Transplantation,NeurodegenerationandOncology等領(lǐng)域范圍的diagnosticmarker,主力產(chǎn)品為:HI VI/IIscore,HTLVI/IIscore,HBVDRv2,HBVgenotyping,HBVPreCore,HPVGenotyping,HIVAntigenmAb,Mycobacteria等等肝炎之偵測(cè).2010年Fujirebio完成收購比利時(shí)Innogenetics INNOGENETICSNVisaninternationalbiotechnologycompanythatdevelopsandmarketsdiagnosticassaysinthefieldsofInfectiousDiseases,GeneticTesting,Transplantation,Neurodegeneration,andOncology,withaspecialfocusonmoleculardiagnosticsandmultiparametertesting.InnogeneticsisaSolvayPharmaceuticalscompany.SolvayPharmaceuticalsistheglobalpharmaceuticalssectoroftheSolvayGroup.